Literature DB >> 6192490

In vitro immunization for the production of antigen-specific lymphocyte hybridomas.

C A Borrebaeck.   

Abstract

Antigen-specific lymphocyte hybridomas have been produced by a simple in vitro immunization procedure. Non-immune spleen cells have been activated in vitro, and the B-cell blasts have subsequently been used for somatic cell hybridization. Hybrids secreting monoclonal antibodies to human myoglobin, pig insulin, and benzo(a)pyrene were obtained with splenocytes that had been immunized 5 days in culture before the hybridization. The frequency of specific hybridomas was the same as or higher than that of hybridomas produced from in vivo-immunized cells, showing the versatility of the procedure when making monoclonal antibodies to haptens and proteins with a conserved structure or to small amounts of antigen. Monoclonal antibodies of both IgG and IgM isotypes could be isolated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192490     DOI: 10.1111/j.1365-3083.1983.tb00829.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Effect of cytokines on specific in vitro immunization of human peripheral B lymphocytes against T-cell dependent antigens.

Authors:  L Danielsson; S A Möller; C A Borrebaeck
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

2.  Concanavalin A-induced B-cell proliferation mediated by allogeneically derived helper factors.

Authors:  S A Möller; L Danielsson; C A Borrebaeck
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

3.  Rapid isolation of K88+ Escherichia coli by using immunomagnetic particles.

Authors:  A Lund; A L Hellemann; F Vartdal
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

4.  Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes.

Authors:  C A Borrebaeck; L Danielsson; S A Möller
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  Human monoclonal antibodies against a recombinant HIV envelope antigen produced by primary in vitro immunization. Characterization and epitope mapping.

Authors:  M Ohlin; P A Broliden; L Danielsson; B Wahren; J Rosen; M Jondal; C A Borrebaeck
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.